Hanson Bryan C — SEC insider filings
SEC reporting owner CIK 1524349. 21 insider filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2020-12-21 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 46.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Solventum Corp (SOLV) | Chief Executive Officer, Director | 8 | — | — | 21 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | President and CEO, Director | 9 | — | — | 21 |
| Walgreens Boots Alliance, Inc. (WBA) | Director | 3 | — | — | 3 |
| 3M CO (MMM) | Group Pres & CEO Health Care | 1 | — | — | 1 |
Insider filings — Hanson Bryan C
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | Solventum Corp (SOLV) | Option exercise (M): 67,261 · Tax withholding (F): 26,468 @ $90.95 · Option exercise (M): 67,261 (derivative) @ $0 | EDGAR |
| 2026-05-15 | 4 | Solventum Corp (SOLV) | Option exercise (M): 34,315 @ $0 · Tax withholding (F): 13,503 @ $74.41 · Option exercise (M): 34,315 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Solventum Corp (SOLV) | Option exercise (M): 31,907 @ $0 · Tax withholding (F): 10,395 @ $69.41 · Grant/award (A): 105,963 (derivative) @ $0 · Option exercise (M): 31,907 (derivative) @ $0 | EDGAR |
| 2025-09-02 | 4 | Solventum Corp (SOLV) | Option exercise (M): 67,261 @ $0 · Tax withholding (F): 26,468 @ $73.09 · Option exercise (M): 67,261 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | Walgreens Boots Alliance, Inc. (WBA) | Grant/award (A): 16,820 @ $0 | EDGAR |
| 2025-05-15 | 4 | Solventum Corp (SOLV) | Option exercise (M): 34,315 @ $0 · Tax withholding (F): 13,503 @ $73.52 · Option exercise (M): 34,315 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | Solventum Corp (SOLV) | Grant/award (A): 95,723 (derivative) @ $0 | EDGAR |
| 2024-11-05 | 4 | Walgreens Boots Alliance, Inc. (WBA) | Grant/award (A): 21,141 @ $0 | EDGAR |
| 2024-09-04 | 4 | Solventum Corp (SOLV) | Option exercise (M): 67,261 @ $0 · Tax withholding (F): 26,468 @ $64.11 · Option exercise (M): 67,261 (derivative) @ $0 | EDGAR |
| 2024-05-15 | 4 | Solventum Corp (SOLV) | Grant/award (A): 102,946 (derivative) @ $0 | EDGAR |
| 2023-11-03 | 4 | Walgreens Boots Alliance, Inc. (WBA) | Grant/award (A): 9,694 @ $0 | EDGAR |
| 2023-09-06 | 4 | 3M CO (MMM) | Grant/award (A): 126,754 (derivative) @ $0 | EDGAR |
| 2023-03-08 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Grant/award (A): 47,625 (derivative) @ $0 | EDGAR |
| 2023-02-23 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Option exercise (M): 15,132 @ $0 · Tax withholding (F): 4,752 @ $124.73 · Option exercise (M): 15,132 (derivative) @ $0 | EDGAR |
| 2022-03-03 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Grant/award (A): 14,680 (derivative) @ $0 · Grant/award (A): 26,524 (derivative) @ $0 | EDGAR |
| 2022-02-23 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Grant/award (A): 166,819 (derivative) @ $0 | EDGAR |
| 2021-12-21 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Option exercise (M): 25,520 @ $0 · Tax withholding (F): 11,826 @ $120.94 · Option exercise (M): 32,950 @ $0 · Tax withholding (F): 15,270 @ $120.94 · Option exercise (M): 25,520 (derivative) @ $0 · Option exercise (M): 32,950 (derivative) @ $0 | EDGAR |
| 2021-03-02 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Option exercise (M): 1,866 @ $0 · Tax withholding (F): 585 @ $163.92 · Option exercise (M): 1,866 (derivative) @ $0 | EDGAR |
| 2021-03-01 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Grant/award (A): 131,698 (derivative) @ $0 | EDGAR |
| 2021-02-22 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Grant/award (A): 1,866 (derivative) @ $0 | EDGAR |
| 2020-12-21 | 4 | ZIMMER BIOMET HOLDINGS, INC. (ZBH) | Option exercise (M): 8,625 @ $0 · Tax withholding (F): 3,997 @ $150.97 · Option exercise (M): 8,625 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-12-17 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1524349 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs